TEVA Teva Pharmaceutical Industries Limited
TEVA Teva Pharmaceutical Industries Limited
Healthcare · Drug Manufacturers - Specialty & Generic
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $31.87 · VWAP $31.46 · +31.9% vs 12m avg buyer
Insiders selling 0 buy / 1 sell · Form 4, 90d $14.4M sold last open-market sell MIGNONE ROBERTO
Cluster EVP, Director + 1 other sold $1.1M, Aug 19–25
Coverage
1 watchlist
TEVA Price Structure
Loading timeframes…
Peers
Every watchlist TEVA belongs to, members best 30-day change first — TEVA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@trace-iran-war-second-and-third-order-effects
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-30: revenue $4.14B, diluted EPS -$0.49, net income -$576M (SEC filing). Across the print the stock moved +11.8% (close before → first close after).
full note →Against street estimates
How TEVA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
TEVA research tape
55 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.